Quantedge Capital Pte LTD Supernus Pharmaceuticals, Inc. Transaction History

Quantedge Capital Pte LTD

  • $328 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$31.09 - $37.88 $1.18 Million - $1.44 Million
-38,000 Reduced 66.78%
18,900 $674,000
Q3 2022

Nov 10, 2022
BUY
$28.79 - $35.41 $1.02 Million - $1.26 Million
35,600 Added 167.14%
56,900 $1.93 Million
Q2 2022

Aug 12, 2022
BUY
$25.33 - $34.25 $539,529 - $729,525
21,300 New
21,300 $616,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email